Phase 2 Trial of Retatrutide for Obesity and Overweight Without Diabetes Begins | Retatrutide News

Eli Lilly is conducting a Phase 2 trial of retatrutide for obesity without type 2 diabetes. The study will assess the drug's efficacy and safety in conj...
Clinical Trials · November 3, 2026